Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Fesco intends to increase its container fleet to 160 thousand TEU in 2023

4/19/23 FESH

Yandex Go launched electric scooter rentals of its own design

4/19/23 YNDX

Magnit scales smart scales technology

4/19/23 MGNT

Inter RAO will increase generation by 2.7% in 2022

4/19/23 IRAO

Sberbank tests Russia's first smartphone-controlled ATM

4/19/23 SBER

Fesco seeks opportunities to buy container terminals

4/19/23 FESH

VK data center in Domodedovo is planned to be completed by the end of the year

4/19/23 VKCO

Fesco fleet is full of six container ships with capacity of 2.5 thousand TEU each

4/19/23 FESH

Netflix reported for 3 months of 2023

4/19/23 NFLX

RussNeft reported for 3 months of 2023 according to RAS

4/19/23 RNFT